October is generally the month that "awareness" around breast cancer research peaks, but it's important to be aware of ...

Chemotherapy targets cancer cells by disrupting DNA replication and mitotic processes, despite side effects on healthy cells.

EGFR tyrosine kinase inhibitors (TKIs) are effective treatments for EGFR-mutant non-small cell lung cancer (NSCLC). However, ...

The POLAR genomic signature can help predict the patients with early breast cancer who may benefit from adjuvant radiotherapy ...

Radiation therapy (RT) is a cornerstone in cancer treatment, known for its ability to induce tumor cell death and modulate ...